课题基金 / 基金详情

Nanoscale Functional Dendrimer-DNA Assemblies

Nanoscale Functional Dendrimer-DNA Assemblies
纳米级功能性树枝状聚合物-DNA 组装体
批准号:
7390402
负责人:
MARK W. GRINSTAFF
金额:
$16.25万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-04 至 2009-11-30

项目摘要

项目成果

MARK W. GRINSTAFF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal describes the preparation and evaluation of new gene delivery vehicles composed of dendritic amphiphiles and DMA. These new functional dendritic amphiphiles undergo an electrostatic transition from cationic to anionic via an esterase-catalyzed reaction intracellularly to release DMA from the nanoscale assembly. We hypothesize that this change in electrostatic interactions with DNA will lead to increased gene transfection levels. A detailed, systematic investigation is proposed that entails the following three specific aims for this three-year R21 proposal: Aim 1. Determine the key molecular characteristics of the dendritic amphiphile required for binding and release of DNA. Aim 2. Characterize the nanoscale assemblies formed with the dendritic amphiphiles, and dendritic amphiphiles and DNA. Aim 3. Evaluate functional interactions of dendritic amphiphile/DNA assemblies with cells in vitro and deliver the p53 gene to colon cancer cells. The results of successful completion of this study will be: 1) one or more functional dendritic amphiphiles for delivery of the p53 gene to colon cancer cells; 2) a database of structure-property relationships; and 3) insight into the design of optimized dendritic vectors. These studies will also provide detailed physicochemical and biological information on this new class of dendritic amphiphiles and their corresponding assemblies, which is key for the future development of functional dendrimer/DNA assemblies for gene delivery. Relevance to Public Health: Innovative strategies to treat or cure colon cancer are still needed. Today, the current treatment protocols have resulted in improved patient care but the response rate remains only about 35% for metastatic colon cancer patients. In this proposal new well-defined polymers are described for the delivery of a tumor suppressor gene for the treatment of colon cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
R21: A novel antibody-drug conjugate for treatment of squamous cell lung carcinoma
R21: A novel antibody-drug conjugate for treatment of squamous cell lung carcinoma
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
海外基金